Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.95 is in line with its 5-year average of 7.16, near the low end of its 5-year range (3.22–25.32).
As of the fiscal period ended Tuesday, June 30, 2026. 32.54% above its 12-month average of 5.24.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.95.
CURRENT RATIO
6.95
CURRENT RATIO AVG TTM
5.24
CURRENT RATIO AVG 3Y
5.39
CURRENT RATIO AVG 5Y
7.16
CURRENT RATIO AVG 10Y
8.94
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+32.54%
CURRENT VS 3Y AVG
+28.92%
CURRENT VS 5Y AVG
-2.99%
CURRENT VS 10Y AVG
-22.31%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.05
median of 419 covered companies
CURRENT VS SECTOR MEDIAN
+127.77%
vs the sector median at left
Definium Therapeutics, Inc.
Market Cap
$4.81B
Current Ratio
6.95
TTM Avg
5.24
3Y Avg
5.39
5Y Avg
7.16
Market Cap
$4.78B
Current Ratio
4.79
TTM Avg
3.12
3Y Avg
4.00
5Y Avg
4.41
Market Cap
$4.92B
Current Ratio
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$4.50B
Current Ratio
5.08
TTM Avg
3.83
3Y Avg
4.06
5Y Avg
4.06
Market Cap
$5.20B
Current Ratio
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
Market Cap
$5.20B
Current Ratio
4.20
TTM Avg
4.30
3Y Avg
4.12
5Y Avg
3.47
Market Cap
$5.27B
Current Ratio
13.57
TTM Avg
9.78
3Y Avg
9.13
5Y Avg
11.38
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | $4.81B | 6.95 | 5.24 | 5.39 | 7.16 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.78B | 4.79 | 3.12 | 4.00 | 4.41 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | 26.10 | 14.27 | 14.23 | 14.47 |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | 11.69 | 9.86 | 7.15 | 7.15 |
| Erasca, Inc. (ERAS)vs › | $5.11B | 8.29 | 9.94 | 10.32 | 11.01 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | 5.08 | 3.83 | 4.06 | 4.06 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | 7.02 | 8.28 | 8.59 | 7.77 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 4.20 | 4.30 | 4.12 | 3.47 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | 13.57 | 9.78 | 9.13 | 11.38 |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.34B | 16.24 | 19.89 | 20.20 | 22.94 |
Current Ratio
6.95
Quick Ratio
6.95
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 6.95 |
| 2026-03-31 | 4.69 |
| 2025-12-31 | 6.29 |
| 2025-09-30 | 3.30 |
| 2025-06-30 | 4.98 |
| 2025-03-31 | 7.27 |
| 2024-12-31 | 7.25 |
| 2024-09-30 | 9.00 |
| 2024-06-30 | 5.92 |
| 2024-03-31 | 3.91 |
| 2023-12-31 | 3.22 |
| 2023-09-30 | 3.85 |
| 2023-06-30 | 3.41 |
| 2023-03-31 | 5.50 |
| 2022-12-31 | 8.16 |
| 2022-09-30 | 6.01 |
| 2022-06-30 | 13.86 |
| 2022-03-31 | 11.67 |
| 2021-12-31 | 13.18 |
| 2021-09-30 | 25.32 |
| 2021-06-30 | 14.80 |
| 2021-03-31 | 25.16 |
| 2020-12-31 | 27.10 |
| 2020-09-30 | 4.67 |
| 2020-06-30 | 11.82 |
| 2020-03-31 | 8.86 |
| 2019-08-31 | 14.76 |
| 2019-05-31 | 0.60 |
| 2019-02-28 | 1.24 |
| 2018-11-30 | 0.59 |
| 2018-08-31 | 24.14 |
| 2018-05-31 | 5.05 |
| 2018-02-28 | 7.86 |
| 2017-11-30 | 14.99 |
| 2017-08-31 | 6.60 |
| 2017-05-31 | 13.05 |
| 2017-02-28 | 46.45 |
| 2016-11-30 | 13.98 |
